Myotonic Dystrophy

Type: Keyphrase
Name: Myotonic Dystrophy
First reported Jul 20 2014 - Updated Jul 20 2014 - 1 reports

Liz Allen: Where were you on July 20, 1969?

Forty-five years ago tonight, as Neil Armstrong took one small step for man, one giant leap for mankind, I took a midway hop into adulthood when I popped open a Budweiser.We were watching the Apollo 11 landing at my friend Kathy's house when we decided ... [Published Erie Times-News - Jul 20 2014]
First reported Jul 14 2014 - Updated Jul 14 2014 - 1 reports

Prosensa Announces Extraordinary Shareholder Meeting to Appoint Dr. Annalisa Jenkins

(GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA), the Dutch biopharmaceutical company focusing on rare diseases with a high unmet medical need, today convenes an Extraordinary General Meeting of Shareholders on 20 August 2014 at 14:00 CET, at the ... [Published GlobeNewswire - Jul 14 2014]
First reported Jun 30 2014 - Updated Jun 30 2014 - 1 reports

Prosensa Strengthens its Management Team and Supervisory Board with Key Appointments

(GLOBE NEWSWIRE) -- . (NASDAQ: RNA) the Dutch biopharmaceutical company focusing on rare diseases with a high unmet medical need, today announced the appointment of Willem W. van Weperen to the new position of chief commercial officer and the addition ... [Published EMoneyDaily - Jun 30 2014]
First reported Jun 28 2014 - Updated Jun 28 2014 - 1 reports

Woman inspires Michigan man to lose nearly 400 pounds

. -Brian Flemming admits he was morbidly obese, addicted to vodka and extremely depressed. But a stranger, living across the ocean, saved his life."By the time I graduated high school, I was probably around 400 pounds, maybe a little over. Once I got ... [Published ClickOnDetroit.com - Jun 28 2014]
First reported Jun 26 2014 - Updated Jun 26 2014 - 1 reports

Biogen Idec Has Lagged Its Biotech Peers, Now Is The Time To Shine!

Summary The stock is fairly valued on 2015 earnings estimates and earnings growth potential. The company boasts an excellent return on assets. This company has many shots on goal with the products in the pipeline.Biogen Idec Inc. ( BIIB ) is a global ... [Published Seeking Alpha - Jun 26 2014]
First reported Jun 25 2014 - Updated Jun 25 2014 - 1 reports

Isis Pharma Gets $1M Milestone Payment from Glaxo

Isis Pharmaceuticals, Inc. ( ISIS - Analyst Report ) earned a $1 million milestone payment from GlaxoSmithKline ( GSK - Analyst Report ) pertaining to the advancement of ISIS-TTR in a randomized, double-blind, placebo-controlled phase II/III study ... [Published Zacks.com - Jun 25 2014]
First reported Jun 25 2014 - Updated Jun 25 2014 - 1 reports

Isis Pharmaceuticals Initiates Phase 1 Study of ISIS-DMPK Rx to Treat Myotonic Dystrophy Type 1

By a News Reporter-Staff News Editor at Biotech Week Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced that it has initiated a Phase 1 study for ISIS-DMPK(Rx). Isis earned a $14 million milestone payment from Biogen Idec associated with this achievement. ... [Published Pharmacy Choice - Jun 25 2014]
First reported Jun 25 2014 - Updated Jun 25 2014 - 1 reports

Conditions in adults thought of as childhood diseases

There are a number of conditions that are commonly thought of as childhood disorders that can either begin in childhood and extend into adulthood or even start in adolescence or adulthood. These include muscular dystrophy, cerebral palsy, fragile X syndrome ... [Published Ravalli Republic - Jun 25 2014]
First reported Jun 19 2014 - Updated Jun 19 2014 - 1 reports

ISIS PHARMACEUTICALS : Initiates Phase 1 Study of ISIS-DMPK Rx to Treat Myotonic Dystrophy Type 1

By a News Reporter-Staff News Editor at Biotech Week -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced that it has initiated a Phase 1 study for ISIS-DMPK(Rx). Isis earned a $14 million milestone payment from Biogen Idec associated with this achievement. ... [Published 4 Traders - Jun 19 2014]
First reported Jun 18 2014 - Updated Jun 18 2014 - 1 reports

Isis Pharma earns $10 million milestone payment from Biogen Idec

Isis Pharmaceuticals, Inc. has earned a $10 million milestone payment from Biogen Idec associated with the validation of an undisclosed target to treat a neurological disorder.  This is the first milestone payment under Isis' and Biogen Idec's 2013 strategic ... [Published PharmaBiz - Jun 18 2014]
First reported Jun 18 2014 - Updated Jun 18 2014 - 1 reports

Derby pals in bike marathon to raise awareness of medical conditions

TWO women plan to cycle 50 miles to raise awareness of two conditions affecting their families.Friends Vanessa Prueitt, and Deb Turner - both of Derby - will compete in the Cerebral Palsy Sport Great Notts Bike Ride on Sunday.Vanessa, 44, is taking part ... [Published NewsRT.co.uk - Jun 18 2014]
First reported Jun 17 2014 - Updated Jun 17 2014 - 1 reports

Therapeutic methods and agents for treating myotonic dystrophy

The invention provides compounds, compositions and methods for treating myotonic dystrophy. The compounds can selectively bind to CUG repeats in RNA, or to CTG repeats in DNA, and inhibit replication of the nucleic acids. ... [Published Free Patents Online - Jun 17 2014]

Quotes

"My oldest boy never said 'Why me.' He just said life is unfair. I said, 'John, you couldn't have said it any better.' You just don't know what's in store for you" says Harriet, 81
...Jenkins. "With such an extensive research and development pipeline in DMD, I hope to integrate my expertise in global R&D as Prosensa continues to advance its portfolio of innovative exon-skipping technology."
"Instead of sympathy from her, she got angry with me. She basically yelled at me and said, ‘Why are you throwing your life away?’ Flemming said."
...5 drug to enter clinical development," said C Frank Bennett, Ph D , senior vice president of research at Isis. "Myotonic dystrophy represents an ideal opportunity for antisense as the disease-causing gene produces a toxic RNA, which is not accessible by traditional therapeutic approaches but is uniquely accessible with our antisense technology. We look forward to rapidly advancing the development of ISIS-DMPK(Rx)."

More Content

All (23) | News (21) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Liz Allen: Where were you on July 20, 1969? [Published Erie Times-News - Jul 20 2014]
Prosensa Announces Extraordinary Shareholder Me... [Published GlobeNewswire - Jul 14 2014]
Prosensa Strengthens its Management Team and Su... [Published EMoneyDaily - Jun 30 2014]
Woman inspires Michigan man to lose nearly 400 ... [Published ClickOnDetroit.com - Jun 28 2014]
Biogen Idec Has Lagged Its Biotech Peers, Now I... [Published Seeking Alpha - Jun 26 2014]
Isis Pharma Gets $1M Milestone Payment from Glaxo [Published Zacks.com - Jun 25 2014]
Isis Pharmaceuticals Initiates Phase 1 Study of... [Published Pharmacy Choice - Jun 25 2014]
Conditions in adults thought of as childhood di... [Published Ravalli Republic - Jun 25 2014]
ISIS PHARMACEUTICALS : Initiates Phase 1 Study ... [Published 4 Traders - Jun 19 2014]
Group Doctor Visit Improves QOL in Neuromuscula... [Published Diabetes Care - Jun 18 2014]
Isis Pharma earns $10 million milestone payment... [Published PharmaBiz - Jun 18 2014]
Derby pals in bike marathon to raise awareness ... [Published NewsRT.co.uk - Jun 18 2014]
Therapeutic methods and agents for treating myo... [Published Free Patents Online - Jun 17 2014]
Isis Pharmaceuticals Earns $10 Million Mileston... [Published TickerTech.com - Jun 17 2014]
When Research is Personal: Conquering Genetic D... [Published National Institute of Health - YouTube - Apr 28 2014]
‘Draw Something’ Game Helps Man Lose 400 Pounds [Published WREG - Apr 28 2014]
Rosetta, Marina Biotech collaborate to identify... [Published PharmaBiz - Apr 05 2014]
Prosensa Announces Full Year 2013 Financial Res... [Published GlobeNewswire - Mar 18 2014]
Myotonic Dystrophy Foundation Recognizes Rare D... [Published PR Newswire: Policy & Public Interest - Feb 19 2014]
Isis Pharma advances phase II study evaluating ... [Published PharmaBiz - Feb 15 2014]
Production of viral vectors [Published PharmCast - Feb 14 2014]
Methods and compositions for treatment of myoto... [Published PharmCast - Jan 01 2014]
Prosensa Comments on Drisapersen Program Update [Published GlobeNewswire - Dec 19 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
When Research is Personal: Conquering Genetic D... [Published National Institute of Health - YouTube - Apr 28 2014]
<a style="font-size: 15px; font-weight: bold;font-decoration: none;" href="http://www.youtube.com/watch?v=8-tk39oIsZo&feature=youtube_gdata"&gt;When Research is Personal: Conquering Genetic Disease in the Eric T. Wang Lab Eric Wang started his lab ...
Myotonic Dystrophy Foundation Recognizes Rare D... [Published PR Newswire: Policy & Public Interest - Feb 19 2014]
SAN FRANCISCO, Feb. 19, 2014 /PRNewswire-USNewswire/ -- In recognition of Rare Disease Month and Rare Disease Day The Myotonic Dystrophy Foundation (MDF) has released "Hope and Inspiration"—a short eight minute video that brings attention to myotonic ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.